This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Immodulon Therapeutics Limited. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2023
Title: The Innovative Contributions of Satvinder Mudan
Introduction
Satvinder Mudan is a notable inventor based in London, GB. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Mudan is recognized for his work in immunogenic therapies.
Latest Patents
Mudan's latest patents focus on the development of immunomodulators for the treatment and control of neoplastic diseases. His inventions provide methods for patients to undergo immunogenic cell death therapy, which can be administered simultaneously, separately, or sequentially with the immunomodulator. The therapies include a variety of techniques such as microwave irradiation, targeted radiotherapy, cryotherapy, and photodynamic therapy, among others.
Career Highlights
Mudan is currently associated with Immodulon Therapeutics Limited, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, aiming to improve patient outcomes through innovative treatment options.
Collaborations
Mudan collaborates with esteemed colleagues such as Charles Akle and John Grange, contributing to a dynamic research environment focused on groundbreaking cancer therapies.
Conclusion
Satvinder Mudan's contributions to cancer treatment through his innovative patents highlight his commitment to improving healthcare. His work exemplifies the impact of research and innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile